AVR 4.08% $12.49 anteris technologies ltd

Ann: Investor Webinar Presentation, page-95

  1. 714 Posts.
    lightbulb Created with Sketch. 44
    I wouldn't expect an ASX announcement for a patent file. We never got one for Immunotherapies, 3d etc. We got a couple back in 2012 when it was allied health and just getting started.
    Admedus TAVR watch this space though! I'm very excited when you compare to the competition. I'd be a little disappointed if a AHZ TAVR product came out with a Merck or Edwards sticker on it just from a flow on to the other product range effect standpoint.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.